The drug, Wegovy, uses an active ingredient called Semaglutide which is part of a growing class of GLP-1 drugs that make ...
The five-year study explored if the drug sold under the brand names Wegovy, Ozempic and Rybelsus could reduce the risk of ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the amount ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
As a new study finds that drugs such as Ozempic, Wegovy and Rybelsus could cut the risk of heart attacks or strokes among ...
Here, ITV News explores the drugs which have been developed away from their intended uses as they provided unforeseen ...
The weight-loss drug Ozempic stole the show for its ‘revolutionary’ ability to cut stroke risk. but experts reveal that ...
Insects are protein-rich, lower in fat and have less of an impact on the environment than livestock, according to researchers ...